Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:sodium_oxybate
calcium oxybate magnesium oxybate potassium oxybate |
| gptkbp:approvalYear |
2020
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N07XX20
|
| gptkbp:brand |
calcium, magnesium, potassium, and sodium oxybates
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_III_(US)
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xywav
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Jazz_Pharmaceuticals
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:pregnancyCategory |
Not assigned (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:relatedTo |
gptkb:Xyrem
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
narcolepsy
excessive daytime sleepiness cataplexy |
| gptkbp:bfsParent |
gptkb:Sodium_oxybate
|
| gptkbp:bfsLayer |
7
|